Sixty Six Oilfield Services, Inc.OTC: SSOF

Shareholder Update

Medically Minded, Inc. (OTC Pink: MMHC) Releases Shareholder Update

ST. THOMAS, U.S. VIRGIN ISLANDS--(April 11, 2016) -  Medically Minded, Inc. (OTC PINK: MMHC), today released the following shareholder update.

OTC Markets Filings

Our filings due for the period ended March 31, 2016 will be filed within the next several days. We apologize for the unexpected delay and are taking measures to assure timely filings going forward. Management understands the importance of providing disclosure in a timely manner to our shareholders and will make doing so a priority.

Medically Minded, U.S.V.I (“MMUSVI”)

There has been a tremendous amount of positive activity surrounding industrial hemp and medical marijuana in the U.S. Virgins Islands (the “Islands”). Recently an industrial hemp bill has gained support in the Senate and appears to be growing momentum as is moves through the legislative process. Mr. Stephen Jones, the Company’s CEO, has been leading Medically Minded’s initiatives to capitalize on the opportunities this bill is creating for businesses throughout the Islands.

Cannabidiol (“CBD”) Products

The Company has established several distributor opportunities covering a variety of CBD based products. These products include CBD oil, honey, vapes, water enhancers, shampoos, conditioners and body lotions. We are evaluating several additional products to make a part of our line of CBD infused products for the consumer and pet market. As part of our market testing we have secured an initial trial inventory of several of these products. The Company will test market this inventory to determine where to direct its marketing and on which products. This will also initiate the first revenues for the Company. The Company has selected an ecommerce developer for its online store and will have an update on its launch shortly.

Management

As part of the anticipated direction of MMUSVI and efforts in the CBD products division, the Company will be adding management personnel. The Company is in discussions with potential individuals to oversee the Company’s CBD division as well as its corporate filing and governance of being a publicly-traded company. We expect to announce management additions over the next week.

About Cannabidiol (“CBD”) Oil

CBD Rich Hemp Oil is an oil extracted from Industrial Hemp plants (stalks and seeds) with a High Grade of Cannabidiol (CBD). The plants used are specifically and uniquely bred to comprise high concentrations of the naturally occurring Cannabinoid Cannabidiol (CBD). Cannabidiol oil that comes from industrial hemp plants, such as will be the case with our products, are considered by the FDA to be a dietary supplement (not a medication) since they are made from industrial hemp plants.

If you live in the US, this means you don’t need a prescription and can legally purchase and consume Cannabidiol in any state. Cannabidiol from industrial hemp also has the added benefit of having virtually no THC. This is why it’s not possible to get “high” with these products. There simply isn’t enough THC.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE: These statements and products have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. Always check with your physician before starting a new dietary supplement program.

FORWARD LOOKING DISCLAIMER: This release contains forward-looking statements that involve risks and uncertainties. Readers are referred to the Securities and Exchange Commission filings filed by the Company on EDGAR at http://www.sec.gov/edgar.shtml, specifically the most recent reports which identify important risk facts that could cause actual results to differ from those contained in the forward-looking statements. The Company undertakes no obligation to review or confirm analysts' expectations or estimates or to publicly release any revisions to any forward-looking statements. The information contained in this press release should not be construed as any indication of the Company's future stock price, its revenues or results of operations.

Contact:

Stephen A Jones

CEO

Medicallyminded@gmail.com